RxNorm Semantic Concepts Index - 302
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "302".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 30202 | mofebutazone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 30206 | Sulfiram-containing product | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 30206 | Sulfiram-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 30206 | Sulfiram-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 30206 | Sulfiram-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 30206 | Sulfiram-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 30206 | Sulfiram-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 30206 | Sulfiram-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 30218 | morazone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 30218 | morazone | Designated preferred name (PT) | NO | |
| RxCUI: 30218 | morazone | Full form of descriptor (FN) | NO | |
| RxCUI: 3022 | Mercaptamine-containing product | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 3022 | Mercaptamine-containing product | Designated preferred name (PT) | YES | |
| RxCUI: 3022 | Mercaptamine-containing product | Designated preferred name (PT) | YES | |
| RxCUI: 3022 | Mercaptamine-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 3022 | Mercaptamine-containing product | Full form of descriptor (FN) | YES | |
| RxCUI: 3022 | Mercaptamine-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 3022 | Mercaptamine-containing product | Full form of descriptor (FN) | YES | |
| RxCUI: 30225 | morniflumate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 30225 | morniflumate | Designated preferred name (PT) | NO | |
| RxCUI: 30225 | morniflumate | Full form of descriptor (FN) | NO | |
| RxCUI: 30227 | moroxydine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 30227 | moroxydine | Designated preferred name (PT) | NO | |
| RxCUI: 30227 | moroxydine | Full form of descriptor (FN) | NO | |
| RxCUI: 30227 | moroxydine | Designated preferred name (PT) | NO | |
| RxCUI: 30227 | moroxydine | Full form of descriptor (FN) | NO | |
| RxCUI: 302285 | conivaptan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 302285 | conivaptan | Designated preferred name (PT) | YES | |
| RxCUI: 302285 | conivaptan | Full form of descriptor (FN) | YES | |
| RxCUI: 302285 | conivaptan | Designated preferred name (PT) | YES | |
| RxCUI: 302285 | conivaptan | Full form of descriptor (FN) | YES | |
| RxCUI: 3023 | Cysteate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3023 | Cysteate | Designated preferred name (PT) | NO | |
| RxCUI: 3023 | Cysteate | Full form of descriptor (FN) | NO | |
| RxCUI: 30234 | Naloxone reductase | Designated preferred name (PT) | NO | |
| RxCUI: 30234 | Naloxone reductase | Full form of descriptor (FN) | NO | |
| RxCUI: 30234 | Naloxone reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 30236 | Morphine sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 30236 | Morphine sulfate | Designated preferred name (PT) | YES | |
| RxCUI: 30236 | Morphine sulfate | Full form of descriptor (FN) | YES | |
| RxCUI: 30236 | Morphine sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
| RxCUI: 302379 | omalizumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 302379 | omalizumab | Designated preferred name (PT) | YES | |
| RxCUI: 302379 | omalizumab | Full form of descriptor (FN) | YES | |
| RxCUI: 302379 | omalizumab | Designated preferred name (PT) | YES | |
| RxCUI: 302379 | omalizumab | Full form of descriptor (FN) | YES | |
| RxCUI: 3024 | L-cysteine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 3024 | L-cysteine | Designated preferred name (PT) | YES | |
| RxCUI: 3024 | L-cysteine | Full form of descriptor (FN) | YES | |
| RxCUI: 3024 | L-cysteine | Designated preferred name (PT) | YES | |
| RxCUI: 3024 | L-cysteine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 3024 | L-cysteine | Full form of descriptor (FN) | YES | |
| RxCUI: 302490 | Ximelagatran | Designated preferred name (PT) | NO | |
| RxCUI: 302490 | Ximelagatran | Full form of descriptor (FN) | NO | |
| RxCUI: 30257 | moxonidine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 30257 | moxonidine | Designated preferred name (PT) | NO | |
| RxCUI: 30257 | moxonidine | Full form of descriptor (FN) | NO | |
| RxCUI: 30257 | moxonidine | Designated preferred name (PT) | NO | |
| RxCUI: 30257 | moxonidine | Full form of descriptor (FN) | NO | |
| RxCUI: 30281 | Messenger ribonucleic acid (nucleoside-O^2^)'-methyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 30281 | Messenger ribonucleic acid (nucleoside-O^2^)'-methyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 30281 | Messenger ribonucleic acid (nucleoside-O^2^)'-methyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 302893 | Hepcidin | Designated preferred name (PT) | NO | |
| RxCUI: 302893 | Hepcidin | Full form of descriptor (FN) | NO |